Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
176M
-
Number of holders
-
202
-
Total 13F shares, excl. options
-
75.6M
-
Shares change
-
+8.61M
-
Total reported value, excl. options
-
$2.63B
-
Value change
-
+$299M
-
Put/Call ratio
-
2.09
-
Number of buys
-
121
-
Number of sells
-
-73
-
Price
-
$34.85
Significant Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q4 2017
244 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock, par value $0.001 per share as of Q4 2017.
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 202 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.6M shares
of 176M outstanding shares and own 43.06% of the company stock.
Largest 10 shareholders include FMR LLC (9.08M shares), BlackRock Inc. (4.97M shares), JPMORGAN CHASE & CO (4.61M shares), ALLIANCEBERNSTEIN L.P. (4.47M shares), Vanguard Group Inc (3.92M shares), WELLINGTON MANAGEMENT GROUP LLP (3.28M shares), JANUS HENDERSON GROUP PLC (2.71M shares), EAGLE ASSET MANAGEMENT INC (2.45M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.99M shares), and BAMCO INC /NY/ (1.93M shares).
This table shows the top 202 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.